19
Participants
Start Date
October 12, 2010
Primary Completion Date
June 27, 2012
Study Completion Date
June 27, 2012
CS-1008
CS-1008 was administered once weekly as an intravenous infusion over 30 ± 10 minutes at a dose range of 0.2 to 6 mg/kg. On Days 1 and 36, CS-1008 infusions were radiolabeled with 111\^In (5-7 mCi).
Ludwig Institute Tumor Targeting Program, Austin Health, Melbourne
Lead Sponsor
Collaborators (1)
Daiichi Sankyo
INDUSTRY
Ludwig Institute for Cancer Research
OTHER